Skip to content

Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis

Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis: A Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04997967
Enrollment
100
Registered
2021-08-10
Start date
2020-07-01
Completion date
2021-08-31
Last updated
2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conscious Sedation Failure During Procedure

Brief summary

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a lengthy and uncomfortable procedure that requires adequate sedation. Propofol is the commonly used sedative during ERCP. However, dose dependent cardiac and respiratory depression may occur. Hypotension usually occurs in severe cholangitis which necessitate the use of alternative sedative. The aim is to study the efficacy and safety of ketofol as a sedative during urgent ERCP for severe cholangitis.

Detailed description

This randomized controlled trial was carried out on 96 patients undergoing urgent ERCP for severe cholangitis. Patients were allocated into two groups; group 1: received ketofol and group 2: received propofol. Demographic data, ERCP duration, recovery time, heart rate (HR), mean arterial pressure (MAP), peripheral oxygen saturation, Ramsey Sedation Scale (RSS), pain Numerical Rating Scale (NRS), propofol requirement, adverse events, endoscopists and patients satisfaction were recorded

Interventions

DRUGKetamine/Propofol

The level of sedation was assessed at 1-3 min intervals, and the infusion rate was adjusted accordingly to achieve a Ramsay Sedation Scale (RSS) score of 5. Any movement of the patient was treated by increasing infusion rate and the infusion was discontinued at the end of the procedure. The total propofol consumed was calculated and the recovery time was recorded and calculated as the time from discontinuation of infusion of the study drug till achievement of RSS score of 3. Then patients were discharged to post-anesthesia care unit (PACU) after attaining an Aldrete Recovery Scale Score of 9- 10 \[19\]. Time taken to achieve this score was also recorded.

DRUGPropofol

Sedation was initially started by bolus dose of 0.5 mg/kg propofol IV over 3 minutes then, infusion was started at the rate of 50 µg /kg/min till RSS score of 5.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Severe acute cholangitis of either sex * Aged between 21-70 years * Undergoing urgent therapeutic ERCP for severe cholangitis with American Society of Anaesthesiologist (ASA) Grade II - III.

Exclusion criteria

* Patients who had ASA physical status Grade VI, * Baseline SpO2 \<90%, * Patients who had difficulty in communication, * Patients allergic to the studied medications, * Morbidly obese patients, * Patients with chronic obstructive pulmonary disease, * Complicated airway, * Pregnant patients.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of ketofol in sedation24 hoursThe time to reach Ramsay Sedation Scale score of 5 to ensure adequate sedation. This scale is between 1-6. The score 5 and 6 indicates adequate sedation while score \<5 indicates inadequate sedation.

Secondary

MeasureTime frameDescription
Impact of ketofol on hemodynamics24 hoursHeart rate (beats/min)
Impact of ketofol on oxygen saturation24 hoursPulse oximeter (SO2)

Countries

Egypt

Contacts

Primary ContactHaidi Ramadan, Phd
haidikaram@aun.edu.eg+201028186710

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026